| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.04 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.04 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.05 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.05 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.061 | 0.06 |